| pubmed-article:17472992 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17472992 | lifeskim:mentions | umls-concept:C0009782 | lld:lifeskim |
| pubmed-article:17472992 | lifeskim:mentions | umls-concept:C0217843 | lld:lifeskim |
| pubmed-article:17472992 | lifeskim:mentions | umls-concept:C0152171 | lld:lifeskim |
| pubmed-article:17472992 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:17472992 | lifeskim:mentions | umls-concept:C0680242 | lld:lifeskim |
| pubmed-article:17472992 | lifeskim:mentions | umls-concept:C1704271 | lld:lifeskim |
| pubmed-article:17472992 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:17472992 | pubmed:dateCreated | 2007-10-15 | lld:pubmed |
| pubmed-article:17472992 | pubmed:abstractText | Endothelin receptor antagonism has become an important component in the treatment of pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD). The purpose of this study was to analyse the safety and effectiveness of sitaxsentan, a selective antagonist of the ET(A) receptor, in a cohort of patients with PAH and CTD. Short-term clinical and haemodynamic effects and longer-term follow-up data are presented. | lld:pubmed |
| pubmed-article:17472992 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17472992 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17472992 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17472992 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17472992 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17472992 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17472992 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17472992 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17472992 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17472992 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17472992 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:17472992 | pubmed:issn | 0003-4967 | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:HillNicholas... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:McLaughlinVal... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:OudizRonald... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:TapsonVictor... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:RobbinsIvan... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:ShapiroShelle... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:BarstRobyn... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:FrostAdaani... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:GirgisReda... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:LanglebenDavi... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:HornEvelyn... | lld:pubmed |
| pubmed-article:17472992 | pubmed:author | pubmed-author:SeiboldJames... | lld:pubmed |
| pubmed-article:17472992 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17472992 | pubmed:volume | 66 | lld:pubmed |
| pubmed-article:17472992 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17472992 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17472992 | pubmed:pagination | 1467-72 | lld:pubmed |
| pubmed-article:17472992 | pubmed:dateRevised | 2010-11-2 | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:meshHeading | pubmed-meshheading:17472992... | lld:pubmed |
| pubmed-article:17472992 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17472992 | pubmed:articleTitle | Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. | lld:pubmed |
| pubmed-article:17472992 | pubmed:affiliation | Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA. | lld:pubmed |
| pubmed-article:17472992 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17472992 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17472992 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17472992 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17472992 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17472992 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17472992 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17472992 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17472992 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17472992 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17472992 | lld:pubmed |
